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Abstract
Background: Evidence has shown benefits for mental health through aerobic training oriented in percentage of VO2max, indicating the importance of this 
variable for clinical practice. Objective: To validate a method for estimating VO2max using a submaximal protocol in elderly patients with clinically diagnosis 
as major depressive disorder (MDD) and Parkinson’s disease (PD). Methods: The sample comprised 18 patients (64.22 ± 9.92 years) with MDD (n = 7) and 
with PD (n = 11). Three evaluations were performed: I) disease staging, II) direct measurement of VO2max and III) submaximal exercise test. Linear regression 
was performed to verify the accuracy of estimation in VO2max established in ergospirometry and the predicted VO2max from the submaximal test measurement. 
We also analyzed the correlation between the Bland-Altman procedures. Results: The regression analysis showed that VO2max values estimated by submaximal 
protocol associated with the VO2max measured, both in absolute values (R2 = 0.65; SEE = 0.26; p < 0.001) and the relative (R2 = 0.56; SEE = 3.70; p < 0.001). 
The Bland-Altman plots for analysis of agreement of showed a good correlation between the two measures. Discussion: The VO2max predicted by submaximal 
protocol demonstrated satisfactory criterion validity and simple execution compared to ergospirometry.
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Resumo
Contexto: Evidências demonstram benefícios para a saúde mental com o treinamento aeróbico orientado em percentuais do VO2max, indicando a importância 
dessa variável para a prática clínica. Objetivo: Validar um método para estimar o VO2max por meio de um protocolo submáximo em idosos com diagnóstico 
clínico de transtorno depressivo maior (DM) e doença de Parkinson (DP). Métodos: A amostra foi composta por 18 pacientes (64,22 ± 9,92 anos; sete pacientes 
com DM e 11 com DP). Foram realizadas três avaliações: I) estadiamento da doença, II) mensuração direta de VO2max e III) teste de esforço submáximo. Foi 
realizada regressão linear para verificar a precisão de estimativa do VO2max estabelecido na ergoespirometria pelo VO2max predito no teste submáximo. Também 
foi analisada a concordância de Bland-Altman entre os procedimentos. Resultados: A análise de regressão mostrou que os valores de VO2max estimados pelo 
protocolo submáximo associam-se com o VO2max medido, tanto no valor absoluto (R2 = 0,65; EPE = 0,26 ; p < 0,001) quanto no relativo (R2 = 0,56; EPE = 3,70; 
p < 0,001). A análise de concordância de Bland-Altman mostrou boa associação entre as duas medidas. Conclusão: O VO2max predito por meio do protocolo 
submáximo demonstrou satisfatória validade de critério e simples execução comparado à ergoespirometria.
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Introduction
Major depressive disorder (MDD) and Parkinson’s disease (PD) are 
highly prevalent disorders representing about 7% and 1%-2% of the 
elderly population, respectively1,2. In addition to the specific symp-
toms, there is also comorbidity with cardiovascular and metabolic 
diseases which compromise the quality of life and increase the risk 
of death3. MDD is associated with hypothalamic-pituitary-adrenal 
(HPA) axis hyperactivity, elevated cortisol levels and increased renin-
-angiotensin-aldosterone activation4,5. These physiological changes 
in depressive individuals contribute to an increased risk of cardio-
vascular diseases, such as hypertension6. Moreover, the cholinergic 
system hyperactivity and the autonomic nervous system impairment 
observed in patients with PD and depression may be associated with 
increased risk of cardiovascular disease7,8.
Low cardiorespiratory fitness9,10 is one of the factors contributing 
to the all cause risk of death including cardiovascular disease. Maxi-
mum values of metabolic equivalent (MET) above 6 MET for women 
and 8 MET for men are associated with a 15% reduced risk of death9. 
With aging, it is expected to occur a decrease of the maximum volume 
of oxygen uptake (VO2max): 10%11 and 5%12 per decade in sedentary 
and active individuals, respectively. On the other hand, aerobic 
exercise contributes to the reduction of the decline of VO2max13. In 
addition to the favorable responses in cardiovascular health, there 
is also a decrease in depressive symptoms and functional decline, as 
well as improvement in cognitive functions, which are potentially 
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efficient in the treatment of mental illness14. However, the prescription 
of aerobic exercise intensity is essential to the efficiency and safety 
of the training program, especially considering the high prevalence 
of cardiovascular disease in this population. 
To determine VO2max, ergospirometry is a direct method conside-
red the “gold standard”, also enabling the identification of ventilation 
thresholds. This measure has high reliability of VO2max in Alzheimer’s 
disease patients (r = 0.94, p < 0.001)15 and PD (r = 0.90)16, being used 
for diagnosis, prognosis and therapeutics, especially for prescribing 
aerobic training. However, its applicability in rehabilitation and 
physical activity centers becomes difficult due to their high financial 
and operational cost. 
Besides the low cardiorespiratory fitness resulting from the 
physical inactivity and specific symptoms of MDD and PD diseases, 
behavioral and motor changes also difficult the maximal tests imple-
mentation in these patients. Loss of pleasure and energy are depres-
sive symptoms common in MDD and can difficult the performance 
of a maximal exercise test. On the other hand, some PD symptoms, 
such as tremor, rigidity, bradykinesia and postural instability may 
difficult the implementation of the test due to problems in motor 
skills. Moreover, in more advanced stages of MD and PD diseases 
these symptoms may worsen. Because of that, the target intensity in 
maximum tests is rarely reached by these patients. Thus, sometimes 
it is necessary and recommended the use of metabolic equations 
suggested by the American College of Sports Medicine (ACSM) for 
the oxygen uptake estimation, including VO2max17. 
Predictive methods of VO2max through submaximal protocols 
have good reliability18 and may be a simple and low cost alternative 
in clinical interventions for exercise prescription. Recently, Santos et 
al.18 found good reproducibility of a submaximal treadmill protocol 
for obtaining the predicted VO2max (r = 0.89) for both maximum heart 
rate (HRmax) estimated by age (220-age)19 and the frequency peak 
heart (HRpeak) (r = 0.83). Further to the advantages of submaximal 
protocol, the method allows the individualization of the increments 
by stage, being able to adapt the initial loads and intensity settings 
during the procedure, as the speed and inclination to reach the steady 
state in the intensity at 70% of heart rate reserve (HRres). However, 
it is not yet established the validity of this procedure, particularly in 
elderly patients with mental disorders.
This study is meant to bridge the gap to obtain reliable parameters 
for the prescription of aerobic training in elderly diagnosed with 
MDD and PD. Moreover, there are not predictive protocols designed 
for this population. The aim of this study is to establish the criterion 
validity of a protocol of VO2max prediction based on HRres to be used 
in MDD and PD patients.
Methods
Subject
This study is part of a larger project regarding the effect of exercise 
training on the mental health of seniors and obtained approval from 
the research ethics committee of the Institute of Psychiatry, Uni-
versidade Federal do Rio de Janeiro (nº 70Liv2-09). MDD patients 
were diagnosed according to Diagnostic and Statistical Manual of 
Mental Disorders (DSM-IV) criteria and the study performed at 
the Center for Alzheimer’s Disease and Related Disorders, Institute 
of Psychiatry, Universidade Federal do Rio de Janeiro (CDA-IPUB-
-UFRJ). Screening of patients with PD was performed at the Institute 
of Neurology Deolindo Couto (INDC/UFRJ).
Inclusion criteria for MDD were age between 60 and 80 years 
and mild to moderate depressive symptoms assessed by the Hamilton 
Depression Scale (HAM-D) validated for Portuguese20. Inclusion cri-
teria for PD were age between 45 and 70 years, diagnosis of idiopathic 
Parkinson’s disease, stage 1 to 3 in Hoehn-Yahr21. Exclusion criteria 
common to all patients were illiteracy, stroke, associated neurodege-
nerative diseases, Parkinsonism, mental comorbidities, use of other 
treatments such as electroconvulsive therapy, psychotherapy, and 
clinical decompensate diseases. Other exclusion criteria were cardiac 
history of acute myocardial infarction and ischemia, symptoms of 
coronary artery disease (angina), ventricular extrasystole, patients 
who were taking beta-blocker medications. Of the 31 patients en-
rolled, 13 were excluded (nine showed no eligibility criteria for the 
study and four did not attend all visits). The sample consisted of 18 
patients who read and signed an Informed Consent Form. 
Experimental design
The patients made  three visits in the morning with an interval of 
up to two weeks between assessments. For PD patients it was taken 
into consideration the “on-off ” and “wearing-off ” phenomena, 
which are fluctuations of motor skills due to the use of levodopa. 
To avoid impairment of motor skills, patients were assessed during 
“on” period. Patients were submitted to a cognitive evaluation and 
motor skills assessment (for PD). Both disorders were staged using 
the Hamilton Depression Scale (HAM-D)20, the Hoehn-Yahr21 and 
the motor domain of the Unified Scale for Assessment of Parkinson’s 
disease (UPDRS III), all validated for the Portuguese. 
Next, the volunteers underwent direct measurement of VO2max 
through the maximum test protocol (ergospirometry) supervised 
by a cardiologist. On the third visit VO2max was estimated using the 
submaximal protocol18,22. Patients were instructed to eat light meals, 
drink water, did not ingest alcohol and did not smoke on the test 
day. Furthermore, they were instructed not to perform intense effort 
over the past 48 hours before assessments. Before starting the test, 
patients were instructed on the scale of perceived exertion [Borg 
Scale (6-20)]23, and the safety procedures to the test on a treadmill. 
Weight and height were measured using a mechanical platform scale 
(Welmy 110, Welmy Industry and Commerce Ltda.®, SP, Brazil).
Maximal exercise test with gas analysis: The direct measure-
ment through the maximal test with gas analysis was performed at the 
Medicine Exercise Clinic (MEDSPORT), in a room with a tempera-
ture of 23oC and relative humidity of 55%. Heart rate was monitored 
through derivation D2 on electrocardiograph (ECG Digital Elite, 
Micromed Biotechnology Ltda.®, DF, Brazil) and blood pressure 
was measured by a mercury sphygmomanometer (DiagnostixTM, 
American Diagnostic Corporation®, USA). 
The Treadmill Ramp Test Protocol24 (ATL Millennium Super, 
Ltda Inbramed®, RS, Brazil) was chosen because it considers the 
biological individuality of patients. This protocol consisted of conti-
nuous and gradual increased stages according to the adaptation to the 
treadmill each patient. Tests used exclusively walking, in which the 
doctor set the speed and inclination to be achieved by the patient and 
the computerized system (VO2000, Medical Graphics®, 13® PC Ergo 
software version 3.3, RS, Brazil) calculated the rate at which the power 
was increased during testing. The cardiorespiratory variables VO2, 
respiratory exchange ratio (R), carbon dioxide production (VCO2) 
and pulmonary ventilation (VE) were measured using a gas analyzer 
coupled to the computerized system, with samples every 10 seconds.
Systems analysis of O2 and CO2 were calibrated according to 
manufacturer’s specification before each test. The peak oxygen 
consumption (VO2 peak) was considered as highest value obtained at 
the end of the effort. To consider this test as maximum effort some 
criteria were observed, such as to reach a plateau in oxygen uptake, 
perceived exertion above 17 (Borg scale 6-20) and mainly, volitional 
fatigue. Furthermore, the evaluators were alerted to the criteria for 
interruption with diagnostic purposes suggested by ACSM17. 
Submaximal protocol: The testing was performed at the Institute 
of Neurology Deolindo Couto. Vital signs were measured after 10 min 
rest in the supine position in a quiet and refrigerated room. During 
the tests we monitored and recorded heart rate by frequency meters 
every 20 s (model FS3TM, Polar®, Finland), the subjective feeling of 
exertion by the Borg scale (6-20)23 and blood pressure was measured 
and recorded every 2 min through the device (DuraShock, Welch 
Allyn, Tycos®, SC, Brazil).
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To determine the HRres we used the equation (HRmax – HRres) x 
intensity + HRres, in which HRmax = maximum heart rate estimated 
by equation (220 – age)19, HRres = resting heart rate measured after 10 
min of rest the patient in the supine position and intensity = intensity 
that the patient should reach during the test (65% of HRres,) and keep 
the steady-state (70% of HRres).
The submaximal protocol consisted of an initial 3-min warm-up 
on treadmill (JOG model 500, Technogym The Wellness Company®, 
Italy), in which the initial rate varied according to the adaptation 
to the treadmill between patients. The increased metabolic ratio 
for each stage was equivalent to 1 MET and provided by manipu-
lating the speed and inclination on the treadmill. The objective 
was to reach the intensity corresponding to approximately 65% 
of HRres. Once achieved, this exercise intensity was maintained 
for six minutes featuring a steady-state25. By the end of this phase, 
it was expected that the HR was stabilized at approximately 70% 
of HRres. The criteria for interruption of both tests followed the 
recommendations of ACSM17.
The VO2 was obtained by equation: VO2 = [0.1 (speed) + 1.8 
(speed) (inclination/100) + 3.5], in which the speed is given in m/min. 
Finally, VO2max was predicted by the equation: VO2max = [(VO2 – 3.5) / 
3.5% HRres + 3.5], in which the VO2max is expressed in mL.kg-1.min-117.
Statistical analysis
We applied the Shapiro-Wilk and Levene tests to test the distri-
bution and data variance, respectively. A linear regression was 
performed to verify the accuracy of the estimate in VO2max esta-
blished in cardiopulmonary exercise testing by VO2max predicted 
in submaximal test. The accuracy of prediction was established by 
the coefficient of determination and adjusted by the standard error 
of the estimate (SEE). Moreover, to verify the correlation between 
measured VO2max and estimated VO2max it was used the reliability 
analysis Bland-Altman.
The software used for data analysis was the Statistical Package 
for the Social Sciences version 19 (SPSS® Inc., Chicago, IL, USA) and 
a value p ≤ 0.05 was accepted as indicating statistical significance.
Results
The sample consisted of 18 patients, 11 with PD and seven with 
MDD. Patients had a mean age of 64.2 (SD = 9.92) years and mean 
schooling of 9.5 (SD = 4.13) years. The average weight and height 
of all patients was 67 (62.5 to 72.3) kg and 1.63 (SD = 0.09) meters, 
respectively. Among the patients, 11 were taking antiparkinsonian 
medications (61.1%), seven were taking selective serotonin reuptake 
inhibitors (38.9%) and eight were taking antihypertensive medica-
tions (44.4%). There was a normal distribution and homogeneity for 
age, education, mini mental state examination (MMSE), height, body 
mass index, number of medications, HAM-D score and UPDRS. 
Regarding symptoms of the disease, depressive patients had mild 
symptoms of depression assessed by HAM-D (11 ± 6). PD patients 
had a median score of 2.5 (2.0-3.0) on Hoehn Yahr Scale and 31.8 (SD 
= 10.5) points in the evaluation of motor symptoms by UPDRS III. 
All patients had adequate adaptation in both protocols investigated 
and no complications were observed.
All patients showed mean absolute VO2max of 1.6 ± 0.4 L.min-1 
(measured directly) and 1.9 ± 0.4 L.min-1 (indirect measure). The 
VO2max values  were made  relative to the body mass of 23.8 ± 3.8 
mL.kg-1.min-1 (direct measure) 27.5 ± 5.5 mL.kg-1.min-1 (indirect 
measurement). Regression analysis showed that the VO2max values 
estimated by submaximal protocol are associated with VO2max 
measured both in absolute value (R2 = 0.65, F (1,16) = 29.78; SEE 
= 0.26; p < 0.001) and the relative (R2 = 0.56, F (1,16) = 20.76, 
SEE = 3.70, p < 0.001). The Bland-Altman concordance analysis 
presented BIAS -3.70 ± 3.63 (mean, SD) (95% CI, -10.82, 3.41) for 
the relative VO2max and BIAS -0.25 ± 0.25 (95% CI, -0.74, 0.25) for 
the absolute VO2max, showing a good agreement between the two 
methods (Figure 1).
Figure 1. Bland-Altman Plot between relative VO2max (A) and absolute 
VO2max (B) in maximal and submaximal protocols.
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Discussion
This study aimed to investigate the use of an indirect method for 
predicting VO2max based on HRres and VO2res through a submaximal 
protocol in patients with highly prevalent mental and neurodegene-
rative diseases in the elderly population, specifically the MDD and 
PD. The results showed good correlation between directly VO2max me-
asured and VO2max provided by the proposed submaximal protocol, 
with standard error of the estimate of 0.26 L.min-1 and 3.70 mL.kg-1.
min-1. All patients were able to perform the tests without any adverse 
response or impairment during or after the evaluations, highlighting 
the ease of application and safety of the protocol.
According to Bland-Altman analysis, we observed a difference 
between direct and indirect measurement, assuming that there is a 
slight overestimation in indirect measurement. However, the values 
of SEE were similar to those found in the literature22. Through the 
mean VO2max obtained by direct measurement (23.7 mL.kg-1.min-1) 
and the indirect measurement (27.4 mL.kg-1.min-1), it was possible 
to calculate the mean METs (6.8 to 7.8 METs, respectively). It is 
believed that individuals with maximal aerobic capacity of 7.9 METs 
or more have lower mortality rates and less cardiovascular disease9. 
These data indicate the suitability of the method to cardiorespiratory 
evaluation in MDD and PD patients, since they are at greater risk for 
cardiac events3,6. In addition, psychiatric disorders are prevalent in 
cardiac patients who participate in a supervised exercise program, 
even without functional impairment and multiple comorbidities26.
For greater safety, we recommend consideration of the standard 
error of estimate reported and demonstrated by the present study. 
Our data corroborate a previous data in a study which used a cycle 
ergometer through a submaximal protocol ramp with sedentary in-
dividuals which found high reproducibility (r = 0.85, p < 0.001) and 
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validity (r = 0.75, p < 0.001)27. The development of these methods 
or indirect tests aims at helping the cardiovascular evaluation and 
direction for the prescription of exercise training.
The adhesion to exercise program and training effectiveness also 
depends on factors related to prescription, such as the intensity of the 
effort. Too light or too high intensity seems to be associated with a 
worse affective response and possibly lower adherence to an exercise 
program, especially in sedentary individuals28. Furthermore, studies 
have shown an ideal intensity for a better benefit on motor, cognitive, 
and behavioral skills. According to the “inverted U” theory29, mode-
rate intensities promote the best response, requiring strict control of 
this variable in patients with mental disorders30.
According to ACSM guidelines for elderly population31, it is 
recommended to practice 150 minutes per week of physical activity, 
and the frequency with aerobic activity at least three times per week, 
intensity at 40 to 60% of HRres, 11-13 in Borg scale, lasting at least 20 
min. Studies that have investigated the effect of aerobic exercise in 
the treatment of MDD in elderly have used VO2max relative for the 
prescription of training intensity32,33. It has already been demonstrated 
that aerobic exercise performed two to three times a week during 
30 min, with 60% VO2max (12 to 14 on the Borg scale) were effective 
for the additional treatment in MDD32,33. Such evidence supports 
the importance of determining VO2max to prescribe aerobic training.
This study presents some limitations which should be considered, 
for example, the small number of patients and medication used by the 
PD patients, since they reduce the HR. In particular, this aspect may 
explain the slight overestimation of VO2max observed. Future studies 
are needed to replicate these analyzes separately for each population 
taking into consideration the type of medication used. Furthermore, 
it is suggested that future studies compare the prediction equations 
HRmax proposed by Fox et al.19 and Tanaka et al.34. Although the pre-
sent study used only MDD and PD patients, it is expected that the 
method for predicting VO2max from a submaximal protocol can be 
used by patients with other mental disorders. Thus, future research 
should replicate this method with specific populations.
Conclusion
VO2max predicted by submaximal protocol demonstrated satisfactory 
validity criterion and simple implementation when compared to 
ergospirometry. Exercise prescription for older adults with MDD 
and PD can be adequately performed based on physiological varia-
bles obtained by this protocol, which should consider the accuracy 
reported by this study. This recommendation suggests safer and more 
effective aerobic training.
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